Boston Scientific CorporationBSX recently presented favorable real-world data from the TRUE-HD study at the annual congress of the European Heart Rhythm Association (EHRA). This latest move is in line ...
Boston Scientific Corp. reported the U.S. launch of its Directsense technology, a tool to aid electrophysiologists in measuring tissue response to radiofrequency (RF) waves during cardiac ablation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results